Khosla Ventures Adds General Partner, Chief Scientific Officer

Firm Also Announces New Investments in Clean Energy



18 Jul, 2006, 01:00 ET from Khosla Ventures

    MENLO PARK, Calif., July 18 /PRNewswire/ -- Khosla Ventures today
 announced the addition of Samir Kaul as general partner and Doug Cameron as
 chief scientific officer. Kaul and Cameron are joining founder Vinod Khosla
 and general partner David Weiden. Khosla Ventures is a leading venture
 assistance and venture capital firm, on the cutting edge of combining
 science, technology and entrepreneurship.
     Mr. Kaul joins Khosla Ventures from Flagship Ventures. Kaul may be best
 known for his work at the Institute for Genomic Research, where he led the
 Arabidopsis thaliana sequencing project, which resulted in the first
 complete sequencing of a plant genome. While at Flagship Ventures, Kaul
 founded Helicos BioSciences Corporation, a pioneer in high-speed,
 high-sensitivity sequencing of DNA or RNA, and Codon Devices, an innovator
 in the emerging field of synthetic biology. Kaul's background in
 biotechnology will equip Khosla Ventures with the resources to advance the
 firm's ambitious bioenergy and bioproducts platform.
     "My goals have always revolved around combining my scientific and
 entrepreneurial experience to advance technology initiatives," according to
 Kaul. "There is no better place for me to accomplish these goals than at
 Khosla Ventures."
     Mr. Cameron joins Khosla Ventures from Cargill, Incorporated, where he
 built the corporate biotechnology R&D center and was Director of
 Biotechnology for over seven years. While at Cargill, Cameron led research
 in microbial, enzyme and fermentation technology.
     Prior to Cargill, Cameron had an impressive career in the field of
 biochemical engineering, in which he has been active for 25 years.
 Currently serving as consulting professor in Stanford University's
 Department of Chemical Engineering, Cameron spent more than a decade as a
 professor in the Department of Chemical Engineering at the University of
 Wisconsin, Madison. His research group was a pioneer in the field of
 metabolic engineering and its application for the production of industrial
 chemicals such as 1,3-propanediol (PDO), a polymer intermediate now being
 commercialized by DuPont.
     "My research in the areas of microbial fermentation and metabolic
 engineering over the years has convinced me that the chemical industry is
 on the brink of a revolution," said Cameron. "This revolution will be
 comprised of innovations in chemistry and biology; the applications of
 these innovations will lead to new processes and practical renewable
 materials, ranging from fuels to building block chemicals to plastics.
 Khosla Ventures is at the fulcrum of where technology meets
 entrepreneurship. It's a true honor to be here."
     In addition to Khosla Ventures' recent formation of the ethanol
 production company Cilion, the firm has made investments in several
 companies with strategic importance in the area of clean technology,
 including:
     * GreatPoint Energy, which offers a product named Bluegas, a clean
 natural gas derived from coal that meets all natural gas purity
 requirements.
     * Mascoma Corporation, a cellulosic biomass-to-ethanol company, founded
 in 2006, that transforms agricultural and forestry waste into bio-ethanol.
     * Celunol, a leader in microbial fermentation of cellulose to ethanol.
     * Amyris Biotechnologies, a leader in metabolic engineering for the
 production of chemicals and pharmaceuticals.
     * LS9, a company that is applying principles of synthetic biology to
 biofuels.
     "Khosla Ventures has an ambitious mission, and to accomplish our goals
 will require great minds. Samir and Doug are outstanding additions to our
 firm, and most importantly to the entrepreneurs we support," said Vinod
 Khosla. "I'm very excited to welcome them to our team."
     About Khosla Ventures
     Khosla Ventures offers venture assistance, strategic advice and capital
 to entrepreneurs. The firm helps entrepreneurs extend the potential of the
 Internet to new markets such as mobile and supports breakthrough scientific
 work such as bio refineries. The partners have been involved in founding or
 growing billion dollar businesses such as Sun Microsystems, Juniper
 Networks and AOL and pioneering scientific work such as the first complete
 sequencing of a plant genome. Vinod Khosla founded the firm in 2004 and was
 joined by general partners David Weiden and Samir Kaul, as well as chief
 scientific officer Doug Cameron in 2006. The firm's capital comes entirely
 from its own partners and a portion of all profits are donated to
 charitable causes, with an emphasis on micro-finance and affordable
 housing. Khosla Ventures is based in Menlo Park, California.
     Press Contacts:
     For media inquiries, please email kv@outcastpr.com or phone
 415-392-8282.
 
 

SOURCE Khosla Ventures
    MENLO PARK, Calif., July 18 /PRNewswire/ -- Khosla Ventures today
 announced the addition of Samir Kaul as general partner and Doug Cameron as
 chief scientific officer. Kaul and Cameron are joining founder Vinod Khosla
 and general partner David Weiden. Khosla Ventures is a leading venture
 assistance and venture capital firm, on the cutting edge of combining
 science, technology and entrepreneurship.
     Mr. Kaul joins Khosla Ventures from Flagship Ventures. Kaul may be best
 known for his work at the Institute for Genomic Research, where he led the
 Arabidopsis thaliana sequencing project, which resulted in the first
 complete sequencing of a plant genome. While at Flagship Ventures, Kaul
 founded Helicos BioSciences Corporation, a pioneer in high-speed,
 high-sensitivity sequencing of DNA or RNA, and Codon Devices, an innovator
 in the emerging field of synthetic biology. Kaul's background in
 biotechnology will equip Khosla Ventures with the resources to advance the
 firm's ambitious bioenergy and bioproducts platform.
     "My goals have always revolved around combining my scientific and
 entrepreneurial experience to advance technology initiatives," according to
 Kaul. "There is no better place for me to accomplish these goals than at
 Khosla Ventures."
     Mr. Cameron joins Khosla Ventures from Cargill, Incorporated, where he
 built the corporate biotechnology R&D center and was Director of
 Biotechnology for over seven years. While at Cargill, Cameron led research
 in microbial, enzyme and fermentation technology.
     Prior to Cargill, Cameron had an impressive career in the field of
 biochemical engineering, in which he has been active for 25 years.
 Currently serving as consulting professor in Stanford University's
 Department of Chemical Engineering, Cameron spent more than a decade as a
 professor in the Department of Chemical Engineering at the University of
 Wisconsin, Madison. His research group was a pioneer in the field of
 metabolic engineering and its application for the production of industrial
 chemicals such as 1,3-propanediol (PDO), a polymer intermediate now being
 commercialized by DuPont.
     "My research in the areas of microbial fermentation and metabolic
 engineering over the years has convinced me that the chemical industry is
 on the brink of a revolution," said Cameron. "This revolution will be
 comprised of innovations in chemistry and biology; the applications of
 these innovations will lead to new processes and practical renewable
 materials, ranging from fuels to building block chemicals to plastics.
 Khosla Ventures is at the fulcrum of where technology meets
 entrepreneurship. It's a true honor to be here."
     In addition to Khosla Ventures' recent formation of the ethanol
 production company Cilion, the firm has made investments in several
 companies with strategic importance in the area of clean technology,
 including:
     * GreatPoint Energy, which offers a product named Bluegas, a clean
 natural gas derived from coal that meets all natural gas purity
 requirements.
     * Mascoma Corporation, a cellulosic biomass-to-ethanol company, founded
 in 2006, that transforms agricultural and forestry waste into bio-ethanol.
     * Celunol, a leader in microbial fermentation of cellulose to ethanol.
     * Amyris Biotechnologies, a leader in metabolic engineering for the
 production of chemicals and pharmaceuticals.
     * LS9, a company that is applying principles of synthetic biology to
 biofuels.
     "Khosla Ventures has an ambitious mission, and to accomplish our goals
 will require great minds. Samir and Doug are outstanding additions to our
 firm, and most importantly to the entrepreneurs we support," said Vinod
 Khosla. "I'm very excited to welcome them to our team."
     About Khosla Ventures
     Khosla Ventures offers venture assistance, strategic advice and capital
 to entrepreneurs. The firm helps entrepreneurs extend the potential of the
 Internet to new markets such as mobile and supports breakthrough scientific
 work such as bio refineries. The partners have been involved in founding or
 growing billion dollar businesses such as Sun Microsystems, Juniper
 Networks and AOL and pioneering scientific work such as the first complete
 sequencing of a plant genome. Vinod Khosla founded the firm in 2004 and was
 joined by general partners David Weiden and Samir Kaul, as well as chief
 scientific officer Doug Cameron in 2006. The firm's capital comes entirely
 from its own partners and a portion of all profits are donated to
 charitable causes, with an emphasis on micro-finance and affordable
 housing. Khosla Ventures is based in Menlo Park, California.
     Press Contacts:
     For media inquiries, please email kv@outcastpr.com or phone
 415-392-8282.
 
 SOURCE Khosla Ventures